38th Annual J.P. Morgan Healthcare Conferences 13-16 January | Westin St. Francis Hotel, San Francisco, California, USA Meet with the Adrenomed team in San Francisco Link to the Conference
October 2019, by Lauren Martz and Inhua Muijrers-Chen, Associate Editors
25th Annual International Partnering Conference BIO-Europe® November 11-13, 2019, Hamburg, Germany Company Presentation on the 12th of November, 11:15 AM CET, Level 1, Hall B1, Room 6. Speaker: Dr. Frauke Hein, Chief Business Officer Link
Read the full article about Adrenomed on page 104 of the GoingPublic Special Issue “Biotechnologie 2019” (Article in German). Illustration: Adrenomed AG
Proof-of-concept Phase II trial AdrenOSS-2 is assessing first-in-class antibody Adrecizumab, designed to restore and maintain vascular integrity AdrenOSS-2 trial design and Adrecizumab mode of action will be presented at the European Society of Intensive Care
Hennigsdorf/Berlin (Germany), August 29, 2019 – Adrenomed AG, the vascular integrity company, announced today that its Supervisory Board has appointed two new members of the Executive Board. Dr. Jens Schneider-Mergener is Chief Executive Officer (CEO)
Hennigsdorf (Germany), August 13, 2019 – Adrenomed AG, the vascular integrity company, announced today its participation at four upcoming conferences in Europe. Adrenomed representatives will be available for networking and one-to-one meetings at the
32nd European Society of Intensive Care Medicine (ESICM) LIVES 28 September – 2 October | CityCube, Berlin, Germany Talk: October 1st, 16:20 CET, room Stockholm. “Adrenomedullin in sepsis, effect of the non-inhibitory antibody Adrecizumab”, session “Innovation
European Business Development Conference (EBDC) 25-26 September | Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany Spotlight Talk on Sepsis on the 26th of September, 12:00 CET Speaker: Dr. Frauke Hein, Chief Business Officer Link to the Conference
19th Annual Biotech in Europe Forum (Sachs Conference) 25-26 September | Congress Center Basel, Switzerland Company Presentation on the 25th of September, 10:45 CET Speaker: Dr. Frauke Hein, Chief Business Officer Link to the Conference
By loading the map, you agree to Google's privacy policy.
Learn more
© 2024 AdrenoMed AG | Imprint/Impressum | Legal Notice/Datenschutzerklärung | Expanded Access Policy
